NSEGeneral Updates24 Jun 2026 · 24 Jun 2026, 05:48 pm
General Updates
Medplus Health Services Limited · MEDPLUS
✦ AI Summary▼ NegativeRegulatory
MedPlus Health Services Limited has received two suspension orders for a Drug License of a store situated in the state of Andra Pradesh. The suspension is for seven days and may impact the company's revenue by Rs 1.92 lacs and Rs 1.00 lacs respectively.
Analysis Scores
Earnings Impact6/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment2/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Attachments (1)
📄pdf
Download →
MEDPLUS_24062026174525_Intimation.pdf
View document text
MedPlus Health Services Limited
June 24, 2026
The Listing Department The Listing Department
BSE Limited N ational Stock Exchange of India Limited
Phiroze Jeejebhoy Towers, Exchange Plaza, 5th Floor
Dalal Street, Fort, Plot No. C/1, G Block,
Mumbai – 400001 Bandra - Kurla Complex
BSE Scrip Code: 543427 Bandra (East), Mumbai – 400051
NSE Symbol: MEDPLUS
Dear Sir/Madam,
Sub: Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015
We would like to inform you that Optival Health Solutions Private Limited, a subsidiary of the company, has
received two suspension orders for a Drug License of a store situated in the state of Andra Pradesh:
Pursuant to SEBI Listing Regulations read along with SEBI Master Circular No. HO/49/14/14(7)2025-CFD
POD2/I/3762/2026 dated January 30, 2026, the details of the matter are as follows:
Name(s) of the Authority Nature and details of Date of receipt of Details of the Impact on
the action(s) taken, direction or order, violation(s)/ financial
initiated or order(s) including any contravention(s) operation or
passed interim or interim committed or other activities of
orders, or any alleged to be the listed entity,
other committed quantifiable in
communication monetary terms
from the to the extent
authority possible
Assistant Director & District Suspension of Drug Order received on Under Rule 65 of Potential Revenue
Sales Licencing & License for seven 23.06.2026 Drugs and Cosmetics Loss of Rs 1.92
Enforcement Authority, days of store situated Act, 1940 and Drugs lacs.
Rajamahendravaram, East at Kovvada Main and Cosmetics Rules,
Godavari District, Andra Road, Andra Pradesh. 1945
Pradesh.
Assistant Director, District Suspension of Drug Potential Revenue
Sales licensing Authority, License for seven Loss of Rs 1.00
Drugs Control Administration, days of store situated lacs.
Kurnool & Nandyal District, at Bethemcherla
Andra Pradesh. Main Road, Andra
Pradesh.
The same will be available on the website of the Company at www.medplusindia.com and also on the websites
of BSE Limited and National Stock Exchange of India Ltd. viz. www.bseindia.com and www.nseindia.com
respectively. Kindly take the same on records.
For MedPlus Health Services Limited
Gangadi Madhukar Reddy
Managing Director and Chief Executive Officer
DIN: 00098097
040-6724 672
Regd. off. H. No: 11-6-56, Survey No: 257 & 258/1, Opp: IDPL Railway Siding Road, Moosapet, Kukatpally, Hyderabad – 500037, Telangana, India
CIN No: L85110TG2006PLC051845 I Website: www.medplusindia.com I Email:medplus@medplusindia.com